Primerica Q4 adjusted EPS rises 22%

Reuters
02/12
<a href="https://laohu8.com/S/PRI">Primerica</a> Q4 adjusted EPS rises 22%

Overview

  • Financial services provider's adjusted operating EPS rises 22% yr/yr

  • Company authorized new $475 mln share repurchase program through 2026

Outlook

  • Company authorized a $475 mln share repurchase program through 2026

  • Company increased quarterly dividend by 15% to $1.20 per share

Result Drivers

  • ISP SALES GROWTH - Record ISP sales up 24% and client asset values increased 15%, driven by strong demand and favorable equity markets

  • TERM LIFE STABILITY - Term Life segment saw continued earnings growth with direct premiums up 2% and adjusted direct premiums up 4%

  • SALES FORCE STRENGTH - CEO Glenn Williams emphasized the strength of the sales force and commitment to serving middle-income families

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Net Income

$197 mln

Q4 Adjusted operating income

$196.90 mln

Q4 ROE

33.20%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the life & health insurance peer group is "buy."

  • Wall Street's median 12-month price target for Primerica Inc is $306.00, about 15.5% above its February 10 closing price of $264.97

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBw8fmGMGa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10